Published in Medical Letter on the CDC and FDA, October 30th, 2005
Praecis also announced that it received notice from Schering AG of Germany that it was exercising its right to terminate the parties' license, supply and distribution agreement due to Praecis not having received...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.